A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease
NCT07203001 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2026-04-21
Summary
The study is a phase II trial designed to evaluate the clinical efficacy, safety, and tolerability of MAS825 in pediatric and adult participants with Still's disease
Conditions
- Still´s Disease
Interventions
- DRUG
-
MAS825
Experimental drug
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Year
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-03
- Primary Completion
- 2029-05-24
- Completion
- 2029-05-24
- FDA Drug
- Yes
Countries
- United States
- Canada
- France
- Germany
- Italy
- Netherlands
- Spain
- Turkey (Türkiye)
Study Locations
More Related Trials
-
A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
NCT07281079 ·Status: RECRUITING ·Phase: PHASE3
-
Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome
NCT02594215 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of SNC-102 in Subjects With Tourette Syndrome
NCT02217007 ·Status: WITHDRAWN ·Phase: PHASE2
-
An Extension Study to Determine Safety and Efficacy for Pediatric Patients With MPS Type IIIA Disease Who Participated in Study HGT-SAN-093.
NCT02350816 ·Status: TERMINATED ·Phase: PHASE2
-
A Open Label Study in Previously Studied, SBC-103 Treatment Naïve MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously
NCT02618512 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001)
NCT05025241 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Camoteskimab in Participants With Still's Disease
NCT04752371 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)
NCT05371613 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)
NCT04980872 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy
NCT03692312 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety, Tolerability, Pharmacokinetics (PK), and Activity of ATYR1940 in Participants With Muscular Dystrophy - Study Extension
NCT02531217 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD
NCT02451696 ·Status: COMPLETED ·Phase: PHASE2
-
Faslodex in McCune-Albright Syndrome
NCT00278915 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2
NCT06523400 ·Status: RECRUITING ·Phase: PHASE3
-
Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A
NCT03520751 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SEL-302 in Pediatric Subjects With MMA
NCT05778877 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study to Assess Efficacy and Safety of RT001 in Subjects With Infantile Neuroaxonal Dystrophy
NCT03570931 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis
NCT07082543 ·Status: RECRUITING ·Phase: PHASE3
-
PTC299 for Treatment of Neurofibromatosis Type 2
NCT00911248 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)
NCT04573023 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability and Efficacy of BMN 110 in Subjects With Mucopolysaccharidosis IVA
NCT00884949 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy
NCT02858908 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease
NCT01422187 ·Status: COMPLETED ·Phase: PHASE3
-
Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS I
NCT02702115 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Screening Trial for Pain Relief in Schwannomatosis (STARFISH)
NCT05684692 ·Status: RECRUITING ·Phase: PHASE2